Dicarboxylic acid buffering agents: Procter & GambleRecent Research Landscape
The concentration and selection of specific dicarboxylic acids are engineered to control pH stability and enamel remineralization kinetics. This provides superior protection against acid erosion compared to standard monocarboxylic systems.
What technical problems is Procter & Gamble addressing in Dicarboxylic acid buffering agents?
Oral acid neutralization deficiency
(24)evidences
The cluster focuses on dicarboxylic acid buffering agents in dentifrice to counteract pH drops in the mouth. Maintaining pH balance prevents enamel demineralization and enhances the stability of flavor components.
Stannous ion instability
(12)evidences
Tin ions in oral care formulations are highly prone to oxidation and precipitation, which renders them biologically inactive. Stabilizing these ions through ligand buffering ensures long-term antimicrobial efficacy and prevents formula discoloration.
Inadequate gingival tissue contact
(9)evidences
The focus on leave-on compositions for gum health indicates a need to address the continuous breakdown of periodontal tissues. Solving this provides long-term protection against inflammatory recession and bacterial damage.
Stannous ion oxidative instability
(8)evidences
Tin ions in oral care formulations are prone to oxidation and precipitation, which reduces therapeutic efficacy. Stabilizing these ions ensures long-term bioavailability for anti-cavity and anti-sensitivity benefits.
Insufficient enamel fluoride uptake
(7)evidences
The keywords highlight a limitation in how effectively fluoride is absorbed by dental surfaces during cleaning. Addressing this bottleneck enhances the remineralization process and improves long-term resistance to acid-induced decay.
Unstable active agent delivery
(6)evidences
The keywords highlight the use of buffering agents and specific carriers to protect sensitive ingredients like peroxides and active agents in oral formulations. Solving chemical degradation ensures product shelf-life and therapeutic efficacy.